Evaluation criteria for tumor efficacy in the times of immunotherapy
10.3760/cma.j.issn.1673-422X.2018.06.009
- VernacularTitle:免疫治疗时代下肿瘤疗效的评价标准
- Author:
Rilan BAI
1
;
Hanfei GUO
;
Jiuwei CUI
Author Information
1. 吉林大学第一医院肿瘤中心
- Keywords:
Neoplasms;
Immunotherapy;
Response evaluation;
Immune response evaluation criteria in solid tumors
- From:
Journal of International Oncology
2018;45(6):358-361
- CountryChina
- Language:Chinese
-
Abstract:
With the advent of the times of immunotherapy and the emergence of a variety of unconventional response patterns such as delayed response and pseudo-progressive disease,a variety of immune-related efficacy evaluation criteria such as immune-related response criteria,immune-related response evaluation criteria in solid tumor and immune response evaluation criteria in solid tumor have been proposed successively.The evaluation principles and judgment results of these criteria are distinctly different from the traditional response evaluation criteria.In particular,the newly proposed immune response evaluation criteria in solid tumor introduces two new concepts of unconfirmed progressive disease and confirmed progressive disease and provides a new response evaluation model for solid tumors,which is expected to provide solutions to some of the most urgent clinical problems under the times of cancer immunotherapy.
